Quick Answer
PAVmed Inc. reported Stockholders Equity of $33.97 million for the year ending 2025.
- PAVmed Inc. showed an increase of +1,461.4% in Stockholders Equity from 2024 to 2025.
- This data is from PAVmed Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2016: $2.75 million | Q3 2016: $1.14 million | Q4 2016: -$319.1 thousand | Q1 2017: -$4.31 million | Q2 2017: -$5.05 million | Q3 2017: -$5.91 million | Q1 2018: $247.8 thousand | Q2 2018: $6.59 million | Q3 2018: $3.65 million | Q1 2019: -$5.44 million | Q2 2019: -$1.54 million | Q3 2019: -$1.89 million | Q1 2020: -$15.00 million | Q2 2020: -$11.32 million | Q3 2020: -$12.90 million | Q1 2021: $50.29 million | Q2 2021: $42.95 million | Q3 2021: $34.87 million | Q1 2022: $45.93 million | Q2 2022: $21.98 million | Q3 2022: $8.95 million | Q1 2023: -$22.06 million | Q2 2023: -$31.51 million | Q3 2023: -$43.26 million | Q1 2024: -$68.78 million | Q2 2024: -$73.95 million | Q3 2024: -$4.87 million | Q1 2025: $2.50 million | Q1 2025: $44.99 million | Q2 2025: $37.53 million | Q3 2025: $32.52 million.
- Over the full 12 years of available data (2014 to 2025), PAVmed Inc.'s Stockholders Equity has grown by 4,173.5%.
- Historical annual values: Fiscal year 2025: $33.97 million | Fiscal year 2024: -$2.50 million | Fiscal year 2023: -$53.83 million | Fiscal year 2022: -$9.68 million | Fiscal year 2021: $61.67 million | Fiscal year 2020: $1.90 million | Fiscal year 2019: -$3.82 million | Fiscal year 2018: -$2.31 million | Fiscal year 2017: -$2.85 million | Fiscal year 2016: -$319.1 thousand | Fiscal year 2015: $633.9 thousand | Fiscal year 2014: $794.8 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: